R & D centres having scientists skilled in innovative and cost effective technologies for development of NDDS, difficult to formulate products, generics and branded generics. Further to this the finished formulations offered by Innorex are backed by dossiers as per EU-CTD, A-CTD or the regulatory guidelines of the country in which the products are to be marketed.
CRO’s having the expertise in carrying out analytical studies, stability studies, BA BE studies as per ICH guidelines as well as Phase I – Phase IV clinical trials.
Manufacturing facilities having state of the art equipment and certified by WHO, UK MHRA, MCC South Africa, TGA Australia and US FDA.
Our team of highly qualified & experienced personnel, co-ordinate with our collaborators/partners and ensure completion of development projects in a time bound manner, and also ensure manufacturing and supplies on time. Innorex also offers an efficient supply chain & logistic support for meeting delivery commitments.